stockrow
Friday 6 November 2026
Export HCSG’s income statement to Excel — free account
Healthcare Services Group, Inc.
HCSG Healthcare Medical Care Facilities
Healthcare Services Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.29%
- EPS
- −37.3%
- Free cash flow
- −59.8%
Quarter to September 2026, against a year earlier
25.13
1.41
−5.31%
Follow HCSG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.32 | 19.32 | 14.20 | 13.54 |
P/S ratio |
0.75 | 0.70 | 0.91 | 0.74 | |
P/FCF ratio |
9.94 | 8.31 | 11.36 | 13.01 | |
P/Operating CF |
79.59 | 29.63 | 77.22 | 46.10 | |
P/B ratio |
2.71 | 2.52 | 3.25 | 2.62 | |
Price to Tangible BV |
3.27 | 3.03 | 4.02 | 3.28 | |
EV/Sales |
0.66 | 0.60 | 0.81 | 0.64 | |
EV/EBITDA |
18.37 | 14.50 | 10.57 | 9.39 | |
EV/Operating CF |
8.31 | 6.86 | 9.81 | 10.71 | |
EV/FCF |
8.65 | 7.10 | 10.17 | 11.34 | |
Quick Ratio |
3.16 | 2.88 | 2.79 | 2.61 | |
Current Ratio |
3.38 | 3.11 | 3.02 | 2.82 | |
Net Debt/EBITDA |
(6.87) | (5.69) | (7.80) | (5.69) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.30 | 2.26 | 2.30 | 2.27 | |
Operating CF/Net income |
0.56 | 1.68 | 0.96 | 1.21 | |
Capex/Depreciation |
(0.36) | (0.35) | (0.44) | (0.52) | |
Interest Coverage |
69.18 | 92.70 | 35.88 | 100.43 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.90% | 9.08% | 11.17% | 10.10% | |
Intangible Assets out of Total Assets |
0.11 | 0.11 | 0.12 | 0.13 | |
Share Based Compensation of Revenue |
0.67% | 0.60% | 0.60% | 0.61% | |
Graham Net Nets |
0.21 | 0.23 | 0.16 | 0.19 | |
Graham Number |
11.40 | 12.60 | 17.14 | 16.29 | |
Earnings Yield |
4.29% | 5.18% | 7.04% | 7.38% | |
Free Cash Flow Yield |
10.06% | 12.03% | 8.81% | 7.68% | |
Revenue per Share |
6.45 | 6.62 | 6.85 | 7.05 | |
Operating CF per Share |
0.24 | 0.63 | 0.32 | 0.44 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.03) | |
Free Cash Flow per Share |
0.22 | 0.61 | 0.30 | 0.41 | |
Cash per Share |
2.82 | 3.07 | 2.92 | 3.00 | |
Shareholders Equity per Share |
7.05 | 7.35 | 7.55 | 7.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.05 | 7.35 | 7.55 | 7.81 | |
Free Cash Flow |
16.03 | 42.39 | 20.33 | 28.12 | |
Working Capital |
406.04 | 407.86 | 380.41 | 376.34 | |
Capital Expenditures |
(1.36) | (1.34) | (1.54) | (2.05) | |
Net Current Asset Value |
292.37 | 300.15 | 266.51 | 263.81 | |
EV/EBIT |
24.83 | 18.63 | 11.84 | 10.64 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
28.51 | 21.83 | 13.22 | 12.21 | |
| Other line items | |||||
Average Receivables |
358.56 | 364.88 | 323.99 | 331.79 | |
Average Payables |
79.26 | 80.95 | 82.00 | 86.94 | |
Average Inventory |
16.77 | 16.58 | 16.60 | 16.37 | |
Average Assets |
798.51 | 818.90 | 811.53 | 827.35 | |
Average Common Equity |
505.07 | 513.98 | 497.94 | 513.73 |
Columns are period end dates · fundamentals updated 2 Nov 2026